Share

    


In This Section

Home / Learn / Cancer Types / Genitourinary Cancer

Genitourinary Cancer

Through education and advocacy, ACCC seeks to improve cancer outcomes for patients diagnosed with genitourinary cancer.

Genitourinary cancer may include cancers of the urinary system, as well as the reproductive tract. Adrenal, bladder, and kidney (also known as renal) cancers occur in the urinary system, while penile, prostate, and testicular cancers develop in the reproductive tract. Prostate, bladder, and kidney cancers are the most common types of genitourinary cancer, while testicular, penile, and adrenal cancers are the least common.

People who are at higher risk of genitourinary cancer may have a family history of this type of disease. Smoking, age, race/ethnicity, chemical exposures, diet, high blood pressure, and the use of certain medicines or herbal supplements can also increase a person’s risk for certain types of genitourinary cancers.

While some genitourinary cancers have obvious symptoms, others do not. For example, prostate cancer is often referred to as a "silent killer" since some patients do not report having any symptoms prior to diagnosis. However, routine physicals and screenings can help providers find and diagnose these types of cancers early.



Bladder Cancer

Bladder cancer is a common type of cancer that often begins in the urothelial cells, also known as transitional cells, lining the inside of the urethra, bladder, ureters, and renal pelvis.

Prostate Cancer

After skin cancer, prostate cancer is the most diagnosed cancer in men in the United States. The American Cancer Society estimates 268,490 new cases of prostate cancer will be diagnosed in the U.S. in 2022.

Renal Cell Carcinoma

Renal cell carcinoma (kidney cancer) is among the 10 most common cancers in both men and women, with 15-25 percent of patients having metastatic renal cell carcinoma (mRCC) where the cancer has spread to other parts of the body.

On-Demand Webinars

From Oncology Issues

From the ACCCBuzz Blog

Abstracts & Presentations

  • Better Bladder Cancer Care, Closer to Home – [Podcast] Ep 196
    Jun 24, 2025

    Navigating the growing complexity of bladder cancer care is essential to improving patient access and treatment closer to home. In this episode, CANCER BUZZ speaks with Suzanne Merrill, MD, urologic oncologist at Colorado Urology about barriers and solutions to delivering high-quality bladder cancer care in community settings. CANCER BUZZ also speaks with Patrick Hensley, MD, urologist at University of Kentucky Markey Cancer Center, about implementing the Delivering High-Quality Bladder Cancer Care infographic in the community setting. Created by ACCC and BCAN, the infographic describes the 10 elements of excellent bladder cancer care. Cancer programs that align their practices with these guidelines can join a public registry so that patients and caregivers can identify quality bladder cancer care close to where they live.

  • Key Takeaways from a National Quality Improvement Initiative to Address Disparities in Bladder Cancer Care – [Video Podcast] Ep 54
    Feb 26, 2025

    Bladder cancer remains a prevalent disease with significant disparities in care, particularly in underserved populations. To address this, ACCC launched a national quality improvement initiative in three phases: 1. assessment and preparation, 2. action plan implementation, and 3. monitoring for continuous improvement. Dr. Samuel Washington, from the University of California, San Francisco, discussed the initiative’s early findings, highlighting site-specific approaches.

  • [Abstract e18815] Using Real-World Data to Assess Variations in Cost and Healthcare Utilization for Patients Diagnosed with Bladder Cancer
    May 26, 2022
    This is a visual representation of an online publication from the American Society of Clinical Oncology 2022 Annual Meeting, June 3 - 7, 2022.